KMS Medisurgi Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from KMS Medisurgi Ltd. on BSE

Search Inside the pdf :

KMS Medisurgi Ltd.

20 Jun 2025

Board Meeting

KMS Medisurgi Ltd - 540468 - Board Meeting Intimation for Intimation Of The Board Meeting

BSE India

KMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/06/2025 ,inter alia, to consider and approve We wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 27th June 2025 at 02.00 p.m. at the Registered Office of the Company interalia, to discuss, consider and approve the appointment of Ms. Pooja Soni (ACS 51821) as the Company Secretary and Compliance officer of the company.

pdf

KMS Medisurgi Ltd.

30 May 2025

Board Meeting

KMS Medisurgi Ltd - 540468 - Board Meeting Outcome for Submission Of Standalone Audited Financial Results …

BSE India

Submission of Standalone audited financial results for the year ended 31st March, 2025

pdf

KMS Medisurgi Ltd.

30 May 2025

Result

KMS Medisurgi Ltd - 540468 - Submission Of Standalone Audited Financial Results For The Year Ended …

BSE India

Submission of Standalone audited financial result of the company along with statement of assets and liabilities and cash flow.

pdf

KMS Medisurgi Ltd.

30 May 2025

Company Update

KMS Medisurgi Ltd - 540468 - Non-Applicability Of Disclosure Of Related Party Transactions Pursuant To Regulation …

BSE India

Disclosure of related party transaction is not applicable as the company listed its shares on BSE SME Platform.

pdf

KMS Medisurgi Ltd.

30 May 2025

Company Update

KMS Medisurgi Ltd - 540468 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Non-applicability of Regulation 24A of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015.

pdf

KMS Medisurgi Ltd.

22 May 2025, 08:58PM

Board Meeting

KMS Medisurgi Ltd - 540468 - Board Meeting Intimation for Intimation Of Board Meeting To Be …

BSE India

KMS Medisurgi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of KMS Medisurgi Limited ('the Company') will be held on Friday, May 30, 2025 at 01.00 PM at the Registered office of the Company to consider and approve: 1) Audited Financial Results for the financial year ended March 31, 2025 and to take on record Auditor's Report thereon. 2) the appointment of Company Secretary and Compliance Officer in the Company Further, in terms of Company''s "Code of Conduct for Prevention of Insider Trading", the closure of trading window for purchase/sale of securities of the Company by the Designated persons and their immediate relatives has already commenced from April 01, 2025 and will end Forty-Eight (48) hours after the declaration of Financial Results of the Company for the Financial year ended March 31, 2025.

pdf

KMS Medisurgi Ltd.

29 Apr 2025

Corp. Note

KMS Medisurgi Ltd - 540468 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyKMS Medisurgi Ltd 2CIN NO.L51397MH1999PLC119118 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.84 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Company is in process of appointing Company Secretary Designation: Not appointed EmailId: cskms99@gmail.com Name of the Chief Financial Officer: Anand Prataprai Kanakia Designation: CFO EmailId: kanakia3@gmail.com Date: 29/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf